Neuroendocrine tumors and their association with rare tumors: Observation of 4 cases

European Review for Medical and Pharmacological Sciences

Volumn 14, Issue 7, 2010, Pages 577-588

  Cirillo, Fernando ^a  

^a Department of General Surgery   (Italy)

Author keywords

c kit; Gastric carcinoid tumor; Gastrointestinal stromal tumor; Glioblastoma multiforme; Medullary thyroid carcinoma; Merkel cell carcinoma; Neuroendocrine tumor; Squamous cell carcinoma; Synchronous neoplasms; Yolk sac tumor

Indexed keywords

BLEOMYCIN; CALCITONIN; CARCINOEMBRYONIC ANTIGEN; CHROMOGRANIN A; CISPLATIN; ETOPOSIDE; GASTRIN; LANSOPRAZOLE; OCTREOTIDE; OMEPRAZOLE; STEM CELL FACTOR RECEPTOR; TECHNETIUM 99M; TEMOZOLOMIDE;

ABDOMINAL RADIOGRAPHY; AGED; ARTICLE; BRAIN RADIATION; CALCITONIN BLOOD LEVEL; CANCER COMBINATION CHEMOTHERAPY; CANCER INCIDENCE; CARCINOGENESIS; CASE REPORT; CHOLECYSTECTOMY; CHRONIC CHOLECYSTITIS; COMPUTER ASSISTED TOMOGRAPHY; DEATH; DIGESTIVE SYSTEM TUMOR; DISEASE ASSOCIATION; DRUG DOSE INCREASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EMBRYONAL CARCINOMA; ENDOSCOPY; EPITHELIUM TUMOR; FEMALE; GASTROINTESTINAL STROMAL TUMOR; GENOTYPE PHENOTYPE CORRELATION; GLIOBLASTOMA; HUMAN; ITALY; MALE; MERKEL CELL TUMOR; MYELOLIPOMA; NEUROENDOCRINE TUMOR; NUCLEAR MAGNETIC RESONANCE; OBSERVATIONAL STUDY; ORCHIECTOMY; PHEOCHROMOCYTOMA; POSITRON EMISSION TOMOGRAPHY; PROSTATE CARCINOMA; PROTEIN EXPRESSION; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; STOMACH CARCINOID; SURRENALIC MYELOLIPOMA; TESTIS TUMOR; THYROID MEDULLARY CARCINOMA; THYROID SCINTISCANNING; YOLK SAC TUMOR; ADULT; GENE EXPRESSION REGULATION; GENETICS; GENOTYPE; NEOPLASM; PATHOLOGY; PHENOTYPE;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOTYPE; HUMANS; ITALY; MALE; NEOPLASMS; NEUROENDOCRINE TUMORS; PHENOTYPE; PROTO-ONCOGENE PROTEINS C-KIT;

EID: 77955963271     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. CIRILLO F. The epidemiology of neuroendocrine tumours. The dimension of a problem, a problem of dimension. Eur J Oncol 2005; 10: 55-62.
2. SOLCIA E, KLOPPEL G, SOBIN LH. Histological typing of endocrine tumours. New York: Springer-Verlag, Berlin Heidelberg; 2000.
3. BAJETTA E, BOMBARDIERI E, SILVESTRINI R. Basi scientifiche per la definizione di linee-guida in ambito clinico per i Tumori Neuroendocrini del tratto Gastro-Entero-Pancreatico. Alleanza Contro il Cancro, Istituto Superiore della Sanita; 2009, February.
4. YAO JC, HASSAN M, PHAN A, DAGOHOY C, LEARY C, MARES JE, ABDALLA EK, FLEMING JB, VAUTHEY JN, RASHID A, EVANS DB. One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 2008; 26: 3063-3072.
5. CIRILLO F. Tumori neuroendocrini: linee guida per la diagnosi e il trattamento. Eur J Oncol 2004; 9: 37-47.
6. PAPE UF, BERNDT U, MÜLLER-NORDHORN J, BÖHMIG M, ROLL S, KOCH M, WILLICH SN, WIEDENMANN B. Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours. Endocr Relat Cancer 2008; 15: 1083-1097.
7. GODWIN JD, 2ND. Carcinoid tumors. An analysis of 2,837 cases. Cancer 1975; 36: 560-569.
8. MACDONALD RA. A study of 356 carcinoids of the gastrointestinal tract; report of four new cases of the carcinoid syndrome. Am J Med 1956; 21: 867-878.
9. RINDI G. Clinicopathologic aspects of gastric neuroendocrine tumors. Am J Surg Pathol 1995; 19(Suppl 1): S20-29.
10. RINDI G, LUINETTI O, CORNAGGIA M, CAPELLA C, SOLCIA E. Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study. Gastroenterology 1993; 104: 994-1006.
11. AHLMAN H, KÖLBY L, LUNDELL L, OLBE L, WÄNGBERG B, GRANÉRUS G, GRIMELIUS L, NILSSON O. Clinical management of gastric carcinoid tumors. Digestion 1994; 55(Suppl 3): 77-85.
12. AKERSTROM G. Management of carcinoid tumors of the stomach, duodenum, and pancreas. World J Surg 1996; 20: 173-182.
13. RINDI G, BORDI C, RAPPEL S, LA ROSA S, STOLTE M, SOLCIA E. Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior. World J Surg 1996; 20: 168-172.
14. CAMPANA D, NORI F, PEZZILLI R, PISCITELLI L, SANTINI D, BROCCHI E, CORINALDESI R, TOMASSETTI P. Gastric endocrine tumors type I: treatment with long-acting somatostatin analogs. Endocr Relat Cancer 2008; 15: 337-342.
15. ACS. Statistics for 2006. American Cancer Society; 2009 Available from: http://www.cancer.org.
16. CBTRUS. Primary brain tumors in the United States. Statistical report 2004-2005. Central Brain Tumor Registry of the United States; 2009 Available from: http://www.cbtrus.org/reports/2009-NPCR-04-05/CETRUS-NPCR2004-2005-Report- .pdf.
17. SEER CANCER STATISTICS REVIEW 2002-2006. Available from: http://www.seer.cancer.gov/csr/1975-2006/results-merged/sect-03-brain-ons.pdf.
18. KLEIHUES P, BURGER PC, SCHEITHAUER BW. The new WHO classification of brain tumours. Brain Pathol 1993; 3: 255-268.
19. PORTER BF, SUMMERS BA, LELAND MM, HUBBARD GB. Glioblastoma multiforme in three baboons (Papio spp). Vet Pathol 2004; 41: 424-428.
20. TOKER C. Trabecular carcinoma of the skin. Arch Dermatol 1972; 105: 107-110.
21. TANG CK, TOKER C. Trabecular carcinoma of the skin: an ultrastructural study. Cancer 1978; 42: 2311-2321.
22. MEYER-PANNWITT U, KUMMERFELDT K, BOUBARIS P, CASELITZ J. Merkel cell tumor or neuroendocrine skin carcinoma. Langenbecks Arch Chir 1997; 382: 349-358.
23. PENN I, FIRST MR. Merkel's cell carcinoma in organ recipients: report of 41 cases. Transplantation 1999; 68: 1717-1721.
24. CIRILLO F, BUONONATO M, LIMA G, CAFARO I, ALQUATI P. Clinical experience on eight cases of Merkel cell carcinoma. Tumori 2003; 89: 146-151.
25. FOSCHINI MP, EUSEBI V. Divergent differentiation in endocrine and nonendocrine tumors of the skin. Semin Diagn Pathol 2000; 17: 162-168.
26. GOMEZ LG, DIMAIO S, SILVA EG, MACKAY B. Association between neuroendocrine (Merkel cell) carcinoma and squamous carcinoma of the skin. Am J Surg Pathol 1983; 7: 171-177.
27. WALSH NM. Primary neuroendocrine (Merkel cell) carcinoma of the skin: morphologic diversity and implications thereof. Hum Pathol 2001; 32: 680-689.
28. JUNG JY, LEE HJ, PARK CO, LEE JH, LEE KH. Merkel cell carcinoma combined with squamous cell carcinoma. J Dermatol 2007; 34: 671-673.
29. FLETCHER CD, BERMAN JJ, CORLESS C, GORSTEIN F, LASOTA J, LONGLEY BJ, MIETTINEN M, O'LEARY TJ, REMOTTI H, RUBIN BP, SHMOOKLER B, SOBIN LH, WEISS SW. Diagnosis of gastrointestinal stromal tumors: A consensus approach. Hum Pathol 2002; 33: 459-465.
30. MIETTINEN M, LASOTA J. Gastrointestinal stromal tumors-definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch 2001; 438: 1-12.
31. MIETTINEN M, MADIDI M, LASOTA J. Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review. Eur J Cancer 2002; 38: 39-51.
32. CARNEY JA. Gastric stromal sarcoma, pulmonary chondroma, and extra-adrenal paraganglioma (Carney Triad): natural history, adrenocortical component, and possible familial occurrence. Mayo Clin Proc 1999; 74: 543-552.
33. MIETTINEN M, FETSCH JF, SOBIN LH, LASOTA J. Gastrointestinal stromal tumors in patients with neurofibromatosis 1: a clinicopathologic and molecular genetic study of 45 cases. Am J Surg Pathol 2006; 30: 90-96.
34. CHOMPRET A, KANNENGIESSER C, BARROIS M, TERRIER P, DAHAN P, TURSZ T, LENOIR GM, BRESSAC-DE PAILLERETS B. PDGFRA germline mutation in a family with multiple cases of gastrointestinal stromal tumor. Gastroenterology 2004; 126: 318-321.
35. HIROTA S, OKAZAKI T, KITAMURA Y, O'BRIEN P, KAPUSTA L, DARDICK I. Cause of familial and multiple gastrointestinal autonomic nerve tumors with hyperplasia of interstitial cells of Cajal is germline mutation of the c-kit gene. Am J Surg Pathol 2000; 24: 326-327.
36. LI FP, FLETCHER JA, HEINRICH MC, GARBER JE, SALLAN SE, CURIEL-LEWANDROWSKI C, DUENSING A, VAN DE RIJN M, SCHNIPPER LE, DEMETRI GD. Familial gastrointestinal stromal tumor syndrome: phenotypic and molecular features in a kindred. J Clin Oncol 2005; 23: 2735-2743.
37. HARTMANN K, WARDELMANN E, MA Y, MERKELBACHBRUSE S, PREUSSNER LM, WOOLERY C, BALDUS SE, HEINICKE T, THIELE J, BUETTNER R, LONGLEY BJ. Novel germline mutation of KIT associated with familial gastrointestinal stromal tumors and mastocytosis. Gastroenterology 2005; 129: 1042-1046.
38. PAPILLON E, ROLACHON A, CALENDER A, CHABRE O, BARNOUD R, FOURNET J. A malignant gastrointestinal stromal tumour in a patient with multiple endocrine neoplasia type 1. Eur J Gastroenterol Hepatol 2001; 13: 207-211.
39. CORLESS CL, MCGREEVEY L, HALEY A, TOWN A, HEINRICH MC. KIT mutations are common in incidental gastrointestinal stromal tumors one centimeter or less in size. Am J Pathol 2002; 160: 1567-1572.
40. HIROTA S, ISOZAKI K, MORIYAMA Y, HASHIMOTO K, NISHIDA T, ISHIGURO S, KAWANO K, HANADA M, KURATA A, TAKEDA M, MUHAMMAD TUNIO G, MATSUZAWA Y, KANAKURA Y, SHINOMURA Y, KITAMURA Y. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998; 279: 577-580.
41. HIROTA S, OHASHI A, NISHIDA T, ISOZAKI K, KINOSHITA K, SHINOMURA Y, KITAMURA Y. Gain-of-function mutations of platelet-derived growth factor receptor alpha gene in gastrointestinal stromal tumors. Gastroenterology 2003; 125: 660-607.
42. WARDELMANN E, HRYCHYK A, MERKELBACH-BRUSE S, PAULS K, GOLDSTEIN J, HOHENBERGER P, LOSEN I, MANEGOLD C, BÜTTNER R, PIETSCH T. Association of platelet-derived growth factor receptor alpha mutations with gastric primary site and epithelioid or mixed cell morphology in gastrointestinal stromal tumors. J Mol Diagn 2004; 6: 197-204.
43. CASALI PG, JOST L, REICHARDT P, SCHLEMMER M, BLAY JY; ESMO GUIDELINES WORKING GROUP. Gastrointestinal stromal tumors: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2008; 19(Suppl 2): ii35-38.
44. BRANDI ML, GAGEL RF, ANGELI A, BILEZIKIAN JP, BECK-PECCOZ P, BORDI C, CONTE-DEVOLX B, FALCHETTI A, GHERI RG, LIBROIA A, LIPS CJ, LOMBARDI G, MANNELLI M, PACINI F, PONDER BA, RAUE F, SKOGSEID B, TAMBURRANO G, THAKKER RV, THOMPSON NW, TOMASSETTI P, TONELLI F, WELLS SA JR, MARX SJ. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 2001; 86: 5658-5671.
45. VITALE G, CARAGLIA M, CICCARELLI A, LUPOLI G, ABBRUZZESE A, TAGLIAFERRI P, LUPOLI G. Current approaches and perspectives in the therapy of medullary thyroid carcinoma. Cancer 2001; 91: 1797-1808.
46. ROTH LM, TALERMAN A. Recent advances in the pathology and classification of ovarian germ cell tumors. Int J Gynecol Pathol 2006; 25: 305-320.
47. GARNER MJ, TURNER MC, GHADIRIAN P, KREWSKI D. Epidemiology of testicular cancer: an overview. Int J Cancer 2005; 116: 331-339.
48. MOLLER H. Clues to the aetiology of testicular germ cell tumours from descriptive epidemiology. Eur Urol 1993; 23: 8-13; discussion 4-5.
49. GERSHENSON DM. Update on malignant ovarian germ cell tumors. Cancer 1993; 71: 1581-1590.
50. KURMAN RJ, NORRIS HJ. Endodermal sinus tumor of the ovary: a clinical and pathologic analysis of 71 cases. Cancer 1976; 38: 2404-2419.
51. LACK EE, TRAVIS WD, WELCH KJ. Retroperitoneal germ cell tumors in childhood. A clinical and pathologic study of 11 cases. Cancer 1985; 56: 602-608.
52. SHAH JP, KUMAR S, BRYANT CS, ALI-FEHMI R, MALONE JM Jr, DEPPE G, MORRIS RT. A population-based analysis of 788 cases of yolk sac tumors: A comparison of males and females. Int J Cancer 2008; 123: 2671-2675.
53. URBA CZYK K, LIMON J, KOROBOWICZ E, CHOSIA M, SYGUT J, KARCZ D, IWANIK K, OSUCH C, LASOTA J, STACHURA J. Gastrointestinal stromal tumors. A multicenter experience. Pol J Pathol 2005; 56: 51-61.
54. AGAIMY A, WÜNSCH PH, SOBIN LH, LASOTA J, MIETTINEN M. Occurrence of other malignancies in patients with gastrointestinal stromal tumors. Semin Diagn Pathol 2006; 23: 120-129.
55. CHAUDHARY UB, HALDAS JR. Long-term complications of chemotherapy for germ cell tumours. Drugs 2003; 63: 1565-1577.
56. MAIORANA A, FANTE R, MARIA CESINARO A, ADRIANA FANO R. Synchronous occurrence of epithelial and stromal tumors in the stomach: a report of 6 cases. Arch Pathol Lab Med 2000; 124: 682-686.
57. WRONSKI M, ZIARKIEWICZ-WROBLEWSKA B, GORNICKA B, CEBULSKI W, SLODKOWSKI M, WASIUTYNSKI A, KRASNODEBSKI IW. Synchronous occurrence of gastrointestinal stromal tumors and other primary gastrointestinal neoplasms. World J Gastroenterol 2006; 12: 5360-5362.
58. EFSTATHIOS P, ATHANASIOS P, PAPACONSTANTINOU I, ALEXANDROS P, FRANGISCA S, SOTIRIOS G, EVANGELOS F, ATHANASIOS G. Coexistence of gastrointestinal stromal tumor (GIST) and colorectal adenocarcinoma: A case report. World J Surg Oncol 2007; 5: 96.
59. KÖVÉR E, FALUHELYI Z, BOGNER B, KALMÁR K, HORVÁTH G, TORNÓCZKY T. Dual tumours in the GI tract: synchronous and metachronous stromal (GIST) and epithelial/neuroendocrine neoplasms. Magy Onkol 2004; 48: 315-321.
60. MELIS M, CHOI EA, ANDERS R, CHRISTIANSEN P, FICHERA A. Synchronous colorectal adenocarcinoma and gastrointestinal stromal tumor (GIST). Int J Colorectal Dis 2007; 22: 109-114.
61. BURAGAS M, KIDD M, MODLIN IM, CHA C. Multiple gastrointestinal stromal tumors and synchronous ileal carcinoids. Nat Clin Pract Oncol 2005; 2: 166-170; quiz 1.
62. LISZKA Ł, ZIELI SKA-PAJAK E, PAJAK J, GOŁKA D, HUSZNO J. Coexistence of gastrointestinal stromal tumors with other neoplasms. J Gastroenterol 2007; 42: 641-649.
63. FEINMESSER M, HALPERN M, KAGANOVSKY E, BRENNER B, FENIG E, HODAK E, SULKES J, OKON E. c-kit expression in primary and metastatic merkel cell carcinoma. Am J Dermatopathol 2004; 26: 458-462.
64. ISHIKUBO T, AKAGI K, KUROSUMI M, YAMAGUCHI K, FUJIMOTO T, SAKAMOTO H, TANAKA Y, OCHIAI A. Immunohistochemical and mutational analysis of c-kit in gastrointestinal neuroendocrine cell carcinoma. Jpn J Clin Oncol 2006; 36: 494-498.
65. FERRARI L, DELLA TORRE S, COLLINI P, MARTINETTI A, PROCOPIO G, DE DOSSO S, BAJETTA R, CATENA L. Kit protein (CD117) and proliferation index (Ki- 67) evaluation in well and poorly differentiated neuroendocrine tumors. Tumori 2006; 92: 531-535.
66. KARAMAN MW, HERRGARD S, TREIBER DK, GALLANT P, ATTERIDGE CE, CAMPBELL BT, CHAN KW, CICERI P, DAVIS MI, EDEEN PT, FARAONI R, FLOYD M, HUNT JP, LOCKHART DJ, MILANOV ZV, MORRISON MJ, PALLARES G, PATEL HK, PRITCHARD S, WODICKA LM, ZARRINKAR PP. A quantitative analysis of kinase inhibitor selectivity. Nat Biotechnol 2008; 26: 127-132.